Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 248

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 248
---
 investors, or the May Private Placement Warrants, the placement agent, Wainwright, or the Wainwright May Warrants
and Armistice, or the May Armistice Warrants. The following is a brief summary of the October Private Placement Warrants, Wainwright October
Warrants, May Private Placement Warrants, Wainwright May Warrants and the May Armistice Warrants issued in connection with the October
Private Placement and May Private Placement, as applicable, and is subject in all respects to the provisions contained in the applicable
warrants, which are filed as exhibits to our Report on Form 6-K dated October 24, 2019, and for the May Private Placement Warrants, May
Armistice Warrants and Wainwright May Warrants, are filed as exhibits to our Report on Form 6-K dated May 20, 2020. On December 13, 2022,
the exercise price of the October Private Placement Warrants granted to Armistice and the May Private Placement Warrants was reduced to
$8,000.00. Unless otherwise stated, references to warrants in this section include the October Private Placement Warrants, May Private
Placement Warrants, Wainwright October Warrants and Wainwright May Warrants.

Exercisability.
The October Private Placement Warrants and Wainwright October Warrants became exercisable on December 23, 2019. The May Private Placement
Warrants, May Armistice Warrants and Wainwright May Warrants became exercisable upon issuance. The October Private Placement Warrants,
May Private Placement Warrants and May Armistice Warrants will expire five and one-half years from the initial exercise date, and the
Wainwright October Warrants and Wainwright May Warrants will expire on October 22, 2024 and May 18, 2025, respectively. The holder shall
deliver the aggregate exercise price for the Depositary Shares specified in the exercise notice within two trading days following the
date of exercise (subject to the ‘cashless exercise’ arrangements described below).

Cashless Exercise. With respect to the October Private Placement Warrants and Wainwright October Warrants, if, more than six months after
the date of issuance of such warrants, there is no effective registration statement registering, or no current prospectus available for,
the resale of the Depositary Shares underlying such warrants, the holder may exercise the warrant, in whole or in part, on a